Testing effectiveness (Phase 2)UnknownNCT02162914What this trial is testingRegorafenib Versus Placebo to Treat CholangiocarcinomaWho this might be right forCholangiocarcinoma Erasme University Hospital 66
Testing effectiveness (Phase 2)WithdrawnNCT00386516What this trial is testingStudy to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder CancerWho this might be right forCancer of the Bile DuctGallbladder Cancer Galectin Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT03377179What this trial is testingABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced CholangiocarcinomaWho this might be right forCholangiocarcinomaCholangiocarcinoma Non-resectableCholangiocarcinoma, Perihilar+2 more RedHill Biopharma Limited 65
Testing effectiveness (Phase 2)Looking for participantsNCT06313203What this trial is testingHAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)Who this might be right forIntrahepatic CholangiocarcinomaChemotherapy Effect Oslo University Hospital 39
Large-scale testing (Phase 3)Looking for participantsNCT07221253What this trial is testingRilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)Who this might be right forBiliary Tract Cancer AstraZeneca 1,100
Testing effectiveness (Phase 2)Study completedNCT02631590What this trial is testingCopanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced CholangiocarcinomaWho this might be right forBiliary CarcinomaGall Bladder CarcinomaCholangiocarcinoma+1 more H. Lee Moffitt Cancer Center and Research Institute 24
Not applicableStudy completedNCT04069468What this trial is testingNon-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular Carcinoma Boston Scientific Corporation 1,247
Testing effectiveness (Phase 2)Ended earlyNCT02415036What this trial is testingMelphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic CholangiocarcinomaWho this might be right forHepatocellular CarcinomaIntrahepatic Cholangiocarcinoma Delcath Systems Inc. 17
Testing effectiveness (Phase 2)Study completedNCT01572324What this trial is testingStudy of Hepatic Arterial Infusion to Treat Biliary Tract CarcinomasWho this might be right forBiliary Tract Cancer Peking University 37
Testing effectiveness (Phase 2)Study completedNCT02167711What this trial is testingTreatment for Bile Duct Cancer in the LiverWho this might be right forCholangio Carcinoma Chinese University of Hong Kong 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128290What this trial is testingPErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma (Icc) Federation Francophone de Cancerologie Digestive 49
Large-scale testing (Phase 3)Not Yet RecruitingNCT06999512What this trial is testingImpact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for CancerWho this might be right forHepatobiliary CancerPancreatic Cancer Assistance Publique - Hôpitaux de Paris 526
Testing effectiveness (Phase 2)Study completedNCT01247337What this trial is testingIntra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From CholangiocarcinomaWho this might be right forCholangiocarcinoma Dorte Nielsen 56
Early research (Phase 1)Study completedNCT02375880What this trial is testingStudy of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or GallbladderWho this might be right forCarcinoma of Intrahepatic and Extra-hepatic Biliary SystemCarcinoma of GallbladderBile Duct Cancer+1 more Leap Therapeutics, Inc. 51
Testing effectiveness (Phase 2)UnknownNCT00553683What this trial is testingCyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerWho this might be right forBreast CancerColorectal CancerGastric Cancer+5 more Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Looking for participantsNCT03364530What this trial is testingHepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic CholangiocarcinomaWho this might be right forCholangiocarcinoma Non-resectableNon-metastatic University Hospital, Montpellier 40
Testing effectiveness (Phase 2)Ended earlyNCT02994251What this trial is testingA Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic CholangiocarcinomaWho this might be right forUnresectable Intrahepatic Cholangiocarcinoma Yale University 1
Testing effectiveness (Phase 2)Ended earlyNCT00832637What this trial is testingGemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree CancersWho this might be right forHepatocellular CarcinomaCholangiocellular CarcinomaCholangiocarcinoma of the Extrahepatic Bile Duct+4 more New Mexico Cancer Research Alliance 33
Not applicableNo Longer AvailableNCT03414489What this trial is testingExpanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)Who this might be right forCholangiocarcinomaCholangiocarcinoma Non-resectableCholangiocarcinoma, Perihilar+2 more RedHill Biopharma Limited
Testing effectiveness (Phase 2)Study completedNCT01912053What this trial is testingEfficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat CholangiocarcinomaWho this might be right forCholangiocarcinoma Center Eugene Marquis 41